Medicaid Adds Johnson & Johnson COVID-19 Vaccine to Formulary

Published on
March 8, 2021

The US Food and Drug Administration issued an Emergency Use Authorization (EUA) to use the Johnson & Johnson COVID-19 Vaccine on Feb. 27, 2021.  HHSC added the vaccine to the Medicaid and Children’s Health Insurance Program (CHIP) formularies as a payable pharmacy benefit effective Feb. 27.

Manufacturer Drug Name NDC
Johnson & Johnson COVID-19 Vaccine EUA 59676-0580-05
Johnson & Johnson COVID-19 Vaccine EUA 59676-0580-15

To learn more, refer to the VDP COVID-19 vaccine page.